BIRMINGHAM, AL—Hooper Rosa Handley, senior vice president of operations at Medical Properties Trust Inc . (NYSE:), recently sold 3,000 shares of the company’s stock. The transaction, which occurred on December 23, 2024, was executed at a price of $3.67 per share, for a total value of $11,010. The sell-off comes as MPW shares, currently trading at $3.76, show signs of being undervalued by InvestingPro analysis, with the stock in oversold territory and offering a dividend yield of 8.5%.
Following this sale, Handley retains ownership of 356,600 shares in the real estate investment trust, representing a stake in the $2.26 billion market cap company. The transaction was announced in a filing with the Securities and Exchange Commission, signed by W. Zachary Riddle by proxy on December 26, 2024. InvestingPro identifies several additional key metrics and insights for MPW, available in an extensive Pro Research Report covering 1,400+ US stocks.
In other recent news, Medical Properties Trust reported significant developments, starting with financial results. The company reported a GAAP net loss of $1.34 per share for the third quarter of 2024, and its normalized funds from operations were $0.16 per share. The company also highlighted asset sales totaling approximately $2.9 billion year-to-date, with the goal of increasing liquidity and financial flexibility.
Medical Properties Trust has entered into a definitive agreement with Astrana Health for a deal valued at approximately $745 million, which includes the sale of a majority of Prospect’s managed care platform. The company expects net proceeds of about $200 million in cash after settling debt and other obligations, with most of the cash proceeds expected in the first half of 2025.
Truist Securities revised their target price on shares of Medical Properties Trust to $4.00, down from their previous price target of $6.00. The company decided to maintain the “Hold” share rating, after observing unfavorable capital allocation and risk management practices in the company.
In addition, Medical Properties Trust announced a settlement agreement with Viceroy Research, concluding a defamation lawsuit. Details of the agreement remain undisclosed. The company also faces a significant amount of maturing debt, with $4.4 billion in unsecured bonds bearing 3.7% interest maturing between 2025-2027. and an additional $3.5 billion with interest at 3.8% maturing between 2028-2031. These recent developments are crucial for investors to consider when assessing the company’s future prospects.
This article was generated with the help of AI and reviewed by an editor. See our T&C for more information.
